Pharmaco - Press Releases

Date	Title	Company
09-Nov-2021	MorphoSys Announces Departure of Roland Wandeler	MorphoSys AG
09-Nov-2021	Evotec SE announces closing of public offering	Evotec SE
09-Nov-2021	Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021	Vita 34 AG
09-Nov-2021	DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS	Defence Therapeutics Inc.
09-Nov-2021	Birmingham Biotech and the University of Birmingham sign licensing agreement for anti-viral nasal spray against COVID-19	Sciad Newswire
09-Nov-2021	Eckert & Ziegler: One-Off Effects and Robust Operating Business Push Nine-Month Result to Record Level	Eckert & Ziegler Strahlen- und Medizintechnik AG
09-Nov-2021	Formycon Reports its Nine-Month Figures for 2021	Formycon AG
09-Nov-2021	Medios AG still on course for record year	Medios AG
09-Nov-2021	Relief Therapeutics Announces Transitions in Commercial Organization to Implement Next Phase of Corporate Development	RELIEF THERAPEUTICS Holding AG
08-Nov-2021	Asklepios Kliniken: Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer	Asklepios Kliniken
04-Nov-2021	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q3 2021 Financial Results and Highlights Operational Progress (news with additional features)	Vivoryon Therapeutics N.V.
03-Nov-2021	Evotec SE Announces Placement of its Public Offering of American Depositary Shares	Evotec SE
03-Nov-2021	Relief Therapeutics Takes First Step to Create an ADR Program in the United States by filing a Form F-6 Registration Statement with the U.S. Securities and Exchange Commission	RELIEF THERAPEUTICS Holding AG
03-Nov-2021	EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2021 ON 11 NOVEMBER 2021	Evotec SE
03-Nov-2021	STRATEC SE: DR. RUDOLF EUGSTER AS NEW CHAIR OF SUPERVISORY BOARD / PLANNED INCREASE IN NUMBER OF SUPERVISORY BOARD MEMBERS	STRATEC SE
03-Nov-2021	SOTIO to Present New Data from Phase 1 Study of IL-15 Superagonist, SOT101, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting	B3C newswire
03-Nov-2021	Exclusive interview with Professor Sir John Bell announced as Life Science Integrates celebrates ten years of Pharma Integrates	Sciad Newswire
03-Nov-2021	BRAIN Biotech AG: BRAIN and SAMS apply BEC gene-editing technology to Omega-3 Compounds from Marine Organisms	BRAIN Biotech AG
03-Nov-2021	PEGS Europe 2021: ProBioGen's Presentation Shows How the DirectedLuck™ Transpose System Streamlines Cell Line Development	B3C newswire
03-Nov-2021	VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS	Defence Therapeutics Inc.